bioRxivBiophysics
p53 isoforms have a high aggregation propensity, interact with chaperones and lack binding to p53 interaction partners
Anamari Brdar, Christian OsterburgiD, Philipp MünickiD, Anne Christin MacheliD, Rajeshwari Rathore, Susanne Osterburg, Büşra YükseliD, Birgit Schäfer, Kristina DeschiD, Julian D. LangeriD, Ivan ĐikićiD, Volker DötschiD
Abstract
The p53 transcription factor family consists of the three members p53, p63 and p73. Both p63 and p73 exist in different isoforms that are well characterized. Isoforms have also been identified for p53 and it has been proposed that they are responsible for increased cancer metastasis. In contrast to the p63 and p73 isoforms, which do not contain truncations in folded domains, most of the p53 isoforms contain only parts of either the DNA binding domain or the oligomerization domain. To better understand the effect of p53 isoforms in cancer we provide here a comprehensive biochemical characterization. With the exception of the {Delta}40p53 isoform none of the other variants can bind to DNA with high affinity and none can upregulate transcription. Probing with antibodies, DARPins and other interaction partners confirmed that isoforms harboring deletions in the DNA binding domain cannot interact specifically with them, but instead are bound to chaperones and other factors known to interact with misfolded proteins. Expression of isoforms with deletions in the DNA binding domain results in upregulation of cellular chaperones. If the expression level surpasses a threshold, the chaperone system can no longer keep these isoforms soluble resulting in aggregation and co-aggregation with other factors.
- organism: human
- assay: protein structure
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 5
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Δ133p53α and Δ160p53α isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation
Liuqun Zhao, Tanel Punga, Suparna Sanyal·eLifePeer-reviewed·Apr 17, 2025
- Consensus DNA Inhibits p53 Aggregation but Fails to Rescue Mutants
Matthew Steinsaltz, Gregory-Neal W Gomes, Zachary A. Levine·bioRxiv·Jul 24, 2025
- Isoform-specific cofactor recruitment through the intrinsically disordered N-terminus of p63 underlies differential transcriptional activities
Marina F. Nogueira, Michael J. Moore, … Sidharth V. Puram·bioRxiv·Apr 22, 2026
- Oncogenic Phase Transitions: How Mutant p53 Drives Amyloid Formation in p63 and p73 Liquid Droplets
E. C. Petronilho, G. C. C. de Andrade, … J. L. Silva·bioRxiv·Mar 28, 2024
- New Δ246p53 isoform responds to DNA damage to enhance p53 family functions in cellular senescence
S. N. Parkar, A. C. Ramalho, … M. M. Candeias·bioRxiv·Apr 7, 2023
- P53 TAD2 Domain (38-61) Forms Amyloid-like Aggregates in Isolation
K. Gadhave, S. K. Kapuganti, … R. Giri·bioRxiv·Apr 9, 2021